183 related articles for article (PubMed ID: 9030239)
1. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer.
Bhatti RA; Gadarowski J; Ray P
Invasion Metastasis; 1996; 16(2):49-55. PubMed ID: 9030239
[TBL] [Abstract][Full Text] [Related]
2. Metastatic behavior of prostatic tumor as influenced by the hematopoietic and hematogenous factors.
Bhatti RA; Gadarowski JJ; Ray PS
Tumour Biol; 1997; 18(1):1-5. PubMed ID: 8989919
[TBL] [Abstract][Full Text] [Related]
3. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
Karpatkin S; Pearlstein E; Salk PL; Yogeeswaran G
Prog Clin Biol Res; 1982; 89():445-77. PubMed ID: 7111309
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
Ambrus JL; Ambrus CM; Gastpar H
Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
[No Abstract] [Full Text] [Related]
5. [Cancer blood-borne metastasis and platelets].
Tanaka K; Fukumoto S
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
[TBL] [Abstract][Full Text] [Related]
6. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
Ojiro M
Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
[No Abstract] [Full Text] [Related]
7. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
Gastpar H; Ambrus JL; Ambrus CM
Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310
[TBL] [Abstract][Full Text] [Related]
8. [Disordered function of the vascular-thrombocyte link in the hemostatic system during tumor growth].
Liubina LV; Tlepshukov IK
Biull Eksp Biol Med; 1989 Dec; 108(12):716-8. PubMed ID: 2634448
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1228-34. PubMed ID: 3890759
[TBL] [Abstract][Full Text] [Related]
10. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
Honn KV; Menter DG; Onoda JM; Taylor JD; Sloane BF
Symp Fundam Cancer Res; 1983; 36():361-88. PubMed ID: 6382514
[No Abstract] [Full Text] [Related]
11. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
12. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin, a potentiator of tumor cell metastasis.
Tuszynski GP; Gasic TB; Rothman VL; Knudsen KA; Gasic GJ
Cancer Res; 1987 Aug; 47(15):4130-3. PubMed ID: 3607754
[TBL] [Abstract][Full Text] [Related]
14. [Role of blood platelets and prostaglandins in blood-borne metastases].
Tanaka K; Fukumoto S
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1944-7. PubMed ID: 6614932
[TBL] [Abstract][Full Text] [Related]
15. Nb rat prostate adenocarcinoma model: metastasis.
Drago JR; Curley RM; Sipio JC
Anticancer Res; 1985; 5(2):193-6. PubMed ID: 2581494
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet function: does it offer a chance of better cancer progression control?
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic explanation for platelet contribution to cancer metastasis.
Stegner D; Dütting S; Nieswandt B
Thromb Res; 2014 May; 133 Suppl 2():S149-57. PubMed ID: 24862136
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions.
Rickles FR; Hancock WW
Semin Thromb Hemost; 1988 Jan; 14(1):126-32. PubMed ID: 3353730
[TBL] [Abstract][Full Text] [Related]
19. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
20. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
